Individual adjuvant therapy for malignant gliomas based on 06-methylguanine-DNA methyltransferase messenger RNA quantitation by real-time reverse-transcription polymerase chain-reaction

Oncology Reports

Volumn 20, Issue 1, 2008, Pages 165-171

  Tanaka, Satoshi ^a   Akimoto, Jiro ^b   Kobayashi, Ikuo ^c   Oka, Hidehiro ^d   Ujiie, Hiroshi ^e  

^a Kawasaki Hospital   (Japan)

^b TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

06 methylguanine DNA methyltransferase; 1 (4 amino 2 methyl 5 pyrimidynyl) methyl 3 (2 chloroethyl) 3 nitrosourea hydrochloride; Glioma; Individual adjuvant therapy; Real time reverse transcription polymerase chain reaction

Indexed keywords

BETA INTERFERON; CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUORESCENT DYE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE; PLATINUM DERIVATIVE; VINCRISTINE; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RESISTANCE; CANCER SURVIVAL; DRUG RESPONSE; FEMALE; FROZEN SECTION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; SURVIVAL RATE; BRAIN TUMOR; EVIDENCE BASED MEDICINE; GENETICS; GLIOMA; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY;

ADULT; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; EVIDENCE-BASED MEDICINE; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE;

EID: 49849093167     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Silvani A, Milanesi I, Munari L, Broggi G, Botturi M and Boiardi A: Intratumoral beta interferon and systemic chemotherapy. Preliminary data in GBM patients. J Neurosurg Sci 34: 257-259, 1990.
2. Boiardi A, Silvani A, Milanesi I, Botturi M and Broggi G: Primary glial tumor patients treated by combining cis-platin and etoposide. J Neurooncol 11: 165-170, 1991.
3. Yoshida J, Kajita Y, Wakabayashi T and Sugita K: Long-term follow up results of 175 patients with malignant glioma: importance of radical tumor resection and postoperative adjuvant therapy with interferon ACNU and radiation. Acta Neurochir (Wien) 127: 55-59, 1994.
4. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J II, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB and Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980.
5. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
6. Nagane M, Shibui S, Oyama H, Asai A, Kuchino Y and Nomura K: Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastoma. Surg Neurol 44: 462-468, 1995.
7. Tanaka S, Tabuchi S, Watanabe K, Takigawa H, Akatsuka K, Numata H, Hokama Y and Hori T: Preventive effects of interleukin 1β for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies. J Neurooncol 14: 159-168, 1992.
8. 6-methylguanine-DNA methyltransferase in Chinese hamster ovary cells and restoration of cellular resistance to certain N-nitrosourea compounds. Mol Carcinog 4: 482-488, 1991.
9. Bocangel DB, Finkelstein S, Schold SC, Bhakat KK, Mitra S and Kokkinakis DM: Multifaceted resistance of gliomas to temozolomide. Clin Cancer Res 8: 2725-2734, 2002.
10. 6-methylguanine-DNA methyltranspherase gene expression in gliomas by quantitative real-time RT-PCR and clinical response to nitrosoureas. Int J Cancer 103: 67-72, 2003.
11. 6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas. Cell Mol Neurobiol 25: 1067-1071, 2005
12. Aldea C, Alvarez CP, Folgueira L, Delgado R and Otero JR: Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green dye as the detection signal. J Clin Microbiol 40: 1060-1062, 2002.
13. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB and Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491, 1988.
14. Chomczynski P and Sacchi N: Single-step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
15. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS and Tsukada Y: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52: 997-1007, 1983.
16. Tanaka S, Taniura S, Matsumoto S, Kamitani H, Oka H, Fujii K, Nagashima T, Watanabe T and Hori T: Long-term human interferon-β maintenance therapy for malignant gliomas. Int J Immunother 17: 39-49, 1999.
17. Mogami H, Ushio Y, Sano K, Takakura K, Handa H, Yamashita J, Ueki K, Tanaka R, Hatanaka H and Nomura K: Criteria for evaluation treatment regimens for patients with brain tumor. Neurol Med Chir (Tokyo) 26: 191-194, 1986.
18. Gebel JM, Sila CA, Sloan MA, Granger CB, Weisenberger JP, Green CL, Topol EJ and Mahaffey KW: Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparencymal and subdural hematomas complicating the GUSTO-1 trial. Stroke 29: 1799-1801, 1998.
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
20. 6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53: 3416-3420, 1993.
21. Heid CA, Stevens J, Livak KJ and Williams PM: Real-time quantitative PCR. Genome Res 6: 986-994, 1996.
22. Mullah B, Livak K, Andrus A and Kenney P: Efficient synthesis of double dye-labeled oligodeoxyribonucleotide probes and their application in a real-time PCR assay. Nucleic Acids Res 26: 1026-1031, 1998.
23. Ikeda J, Aida T, Sawamura Y, Abe H, Kaneko S, Kashiwaba T, Kawamoto T, Mitsumori K and Saitoh H: Phase II study of DTIC, ACNU, and vincristine combined chemotherapy for supratentorial malignant astrocytomas. Neurol Med Chir (Tokyo) 36: 555-559, 1996.
24. Nomura K, Watanabe T, Nakamura O, Ohira M, Shibui S, Takakura K and Miki Y: Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas. Neurosurg Rev 7: 13-22, 1984.
25. 6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas. Neurosurgery 41: 434-441, 1997.
26. 6-benzylguanine, streptozotocin, and 1, 3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo. Biochem Pharmacol 48: 2127-2134, 1994.
27. 6-methylguanine-DNA methyltranspherase-mediated nimustine resistance in recurrent malignant gliomas by streptozotocin - a preliminary report. Anticancer Res 15: 645-648, 1995.
28. 6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds. Oncol Rep 14: 1275-1280, 2005.
29. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC and Stupp R: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003, 2005.
30. 6-methylguanine-DNA methyltranspherase by promotor hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797, 1999.
31. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB and Herman JG: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350-1354, 2000.
32. 6-methylguaninedeoxyribonucleic acid methyltransferase methylation analysis. Neurol Med Chir (Tokyo) 46: 387-394, 2006.
33. Sackett DL and Rosenberg WM: The need for evidence-based medicine. J R Soc Med 88: 620-624, 1995.
34. Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N and Stupp R: Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10: 1871-1874, 2004.
35. Tolcher AW, Gerson SL, Denis L, Geyer C, Hammond LA, Patnaik A, Goetz AD, Schwartz G, Edwards T, Reyderman L, Statkevich P, Cutler DL and Rowinsky EK: Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer 88: 1004-1011, 2003.
36. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O'Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S and Levin VA: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17: 2762-2771, 1999.
37. Brada M, Hoang-Xuan K, Rampling R, Dietrich PY, Dirix LY, Macdonald D, Heimans JJ, Zonnenberg BA, Bravo-Marques JM, Henriksson R, Stupp R, Yue N, Bruner J, Dugan M, Rao S and Zaknoen S: Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12: 256-266, 2001.